Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Fintel reports that on January 22, 2025, Stifel initiated coverage of Cytokinetics (NasdaqGS:CYTK) with a Buy recommendation.

Stifel analysts kept a Buy rating on Revolve Group (NYSE:RVLV) shares, maintaining a $41.00 price target. The firm is ...

Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...

Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its ...

Cramer recommended buying ASML Holding N.V. ASML, adding that it is a “remarkably great” company. Supporting his view, Wells ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Local leaders descended upon the Stifel Fine Arts Center this evening for the Leadership Wheeling Kickoff Reception for 2025. Leadership Wheeling is a program ...

David Swartz, a senior equity analyst at Morningstar Research Services, told Retail Dive that VF has been “cutting costs and ...

TD Cowen has recently reiterated Nextdecade Corp (NEXT) stock to Buy rating, as announced on June 6, 2024, according to Finviz. Earlier, on August 16, 2023, Wolfe Research had raised the stock from a ...

Papa John's International Inc. 3.55% $1.18B ...